Can neurosteroids serve as treatments for depression and other psychiatric conditions? First coined by the French physiologist Etienne-Emile Baulieu, they are steroids synthesized in the…
The Mount Sinai Health System today announced a $5 million charitable contribution by The Bob & Renee Parsons Foundation to build and support training and…
The Immuno-NeuroPsychiatry Network of the European College of Neuropsychopharmacology recently led what the group claims is the largest systematic review and meta-analysis to date on…
The Feinstein Institutes for Medical Research announced the publication of results from the phase 3 Robin study, which evaluated the safety and efficacy of the…
Sage Therapeutics and Biogen announced positive results from the phase 3 WATERFALL Study in patients with major depressive disorder (MDD) showing zuranolone (SAGE-217/BIIB125) met its primary…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
